2021
Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021
Paltiel AD, Schwartz JL. Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021. Annals Of Internal Medicine 2021, 174: m21-2965. PMID: 34461034, PMCID: PMC8422997, DOI: 10.7326/m21-2965.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19COVID-19 VaccinesDecision Support TechniquesDisease Transmission, InfectiousHumansIncidenceMass ScreeningPandemicsRisk AssessmentSARS-CoV-2United StatesUniversitiesConceptsVaccine effectivenessVaccination coverageAsymptomatic testingBroad vaccination coverageLess frequent testingCOVID-19 prevention strategiesHigh vaccination ratesBase-case assumptionsFall 2021COVID-19 incidenceUnvaccinated personsVaccination ratesDisease progressionHypothetical cohortEffective vaccineAsymptomatic transmissionPrevention strategiesViral transmissionCumulative casesNonpharmaceutical interventionsDrug abuseCumulative infectionsSafe returnVaccinePopulation coverageAdaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic
Yaesoubi R, Havumaki J, Chitwood MH, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic. Medical Decision Making 2021, 41: 386-392. PMID: 33504258, PMCID: PMC8084913, DOI: 10.1177/0272989x21990371.Peer-Reviewed Original ResearchMeSH KeywordsCost-Benefit AnalysisCosts and Cost AnalysisCOVID-19Decision MakingDecision Support TechniquesHumansModels, TheoreticalPandemicsPhysical DistancingPolicyPolicy MakingSARS-CoV-2ConceptsAdaptive policiesClear decision rulesSocial costsEconomic costsPolicy makersPhysical distancing policiesDecision toolPolicyPhysical distancing interventionsDistancing policiesModel-based experimentsDecision rulesReal-time surveillance dataCostCOVID-19 pandemicMakersShorter overall durationMore complex modelsHealth benefitsComplex modelsPandemicCurrent pandemicCOVID-19BenefitsRules
2006
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
Paltiel AD, Walensky RP, Schackman BR, Seage GR, Mercincavage LM, Weinstein MC, Freedberg KA. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Annals Of Internal Medicine 2006, 145: 797-806. PMID: 17146064, DOI: 10.7326/0003-4819-145-11-200612050-00004.Peer-Reviewed Original ResearchConceptsCost-effectiveness ratioDollars/QALYHIV prevalenceAnnual incidenceHIV infectionRoutine HIVAntiretroviral therapyIncremental cost-effectiveness ratioModerate HIV prevalenceUndetected HIV infectionVoluntary HIV screeningUndiagnosed HIV infectionRapid HIV testingHIV patient careHIV transmission riskOne-time screeningQuality-adjusted survivalLifetime medical costsServices Utilization SurveySecondary transmissionBase-case analysisCost-effectiveness analysisHIV screeningObservational cohortHIV testing
2005
Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation
Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R. Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation. Journal Of The American College Of Cardiology 2005, 46: 850-857. PMID: 16139136, DOI: 10.1016/j.jacc.2005.05.061.Peer-Reviewed Original ResearchConceptsElectrophysiologic studySingle-chamber devicesUpgrade rateMost patient populationsSingle-chamber ICDCardioverter-defibrillator implantationSingle university hospitalElectrophysiologic testingRetrospective reviewPatient populationUniversity HospitalDevice selectionInitial implantationPatientsResource utilization costsPerson costsImplantation strategyClinical needICDImplantationExpensive strategyCostly strategyPotential needUtilization costsICD/Optimal Allocation of Testing Dollars: The Example of HIV Counseling, Testing, and Referral
Walensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel AD. Optimal Allocation of Testing Dollars: The Example of HIV Counseling, Testing, and Referral. Medical Decision Making 2005, 25: 321-329. PMID: 15951459, DOI: 10.1177/0272989x05276955.Peer-Reviewed Original ResearchMeSH KeywordsAIDS SerodiagnosisComputer SimulationContinuity of Patient CareCost-Benefit AnalysisCounselingDecision Support TechniquesHIV InfectionsHumansInvestmentsMass ScreeningModels, StatisticalPatient Acceptance of Health CarePrevalenceProbabilityQuality-Adjusted Life YearsReferral and ConsultationResource AllocationSensitivity and SpecificityUnited StatesConceptsCost-effectiveness ratioScreening programUndiagnosed HIV prevalenceHealth screening programHIV testing servicesHIV testingHIV counselingHIV prevalenceLimited screening resourcesClinical impactAppropriate careQALYTesting pathwayTesting servicesScreening resourcesPathway outcomesOptimal targetingCarePathwayEarly stagesHIVReferralAdditional peopleFollowLater stages
2001
Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model
Paltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model. Journal Of Allergy And Clinical Immunology 2001, 108: 39-in4. PMID: 11447380, DOI: 10.1067/mai.2001.116289.Peer-Reviewed Original ResearchConceptsSymptom-free daysCorticosteroid therapyAcute exacerbationModerate asthmaHealth-related qualityPopulation of patientsCost-effectiveness findingsHealth care costsCost-effectiveness analysisTotal health costsAdult asthmaObservational cohortRandomized trialsPatient preferencesPatient surveyClinical impactCorticosteroidsSide effectsCare costsDrug efficacyNatural historyAsthmaIncremental costTherapyMild
2000
Five Minutes with the Governor
Paltiel AD. Five Minutes with the Governor. Medical Decision Making 2000, 20: 239-242. PMID: 10772361, DOI: 10.1177/0272989x0002000209.Peer-Reviewed Original Research
1997
Estimating CE Ratios under Second-order Uncertainty
Stinnett AA, Paltiel AD. Estimating CE Ratios under Second-order Uncertainty. Medical Decision Making 1997, 17: 483-489. PMID: 9343807, DOI: 10.1177/0272989x9701700414.Peer-Reviewed Original ResearchMeSH KeywordsComputer SimulationCost-Benefit AnalysisDecision Support TechniquesHealth Care RationingHumansModels, EconometricProgram EvaluationQuality-Adjusted Life YearsThe Cost-Effectiveness of HIV Testing
Paltiel AD, Kaplan EH. The Cost-Effectiveness of HIV Testing. Medical Decision Making 1997, 17: 490-495. PMID: 9343808, DOI: 10.1177/0272989x9701700415.Peer-Reviewed Original ResearchMeSH KeywordsCost-Benefit AnalysisDecision Support TechniquesHealth PolicyHIV InfectionsHIV SeroprevalenceHumansMass ScreeningModels, EconometricUnited StatesConceptsNational surveillance surveyCost-effectiveness estimatesVoluntary HIVHIV testingSeroprevalence studySurveillance SurveyUninfected peopleTesting ratesUninfected individualsHIVInfectionDifferential participationPrevalenceLittle riskParticipation ratesMagnitude of resultsSeronegativesCost driversOrgan Allocation and the Secretary Problem
Paltiel A. Organ Allocation and the Secretary Problem. Medical Decision Making 1997, 17: 231-232. PMID: 9107620, DOI: 10.1177/0272989x9701700215.Peer-Reviewed Original Research